Atara Biotherapeutics (ATRA) Change in Account Payables (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Change in Account Payables of $510000.0 for Q1 2026, up 117.1% on a YoY basis from $234918.2 in Q1 2025, and up 367.02% quarter-over-quarter from -$191000.0 in Q4 2025.
Atara Biotherapeutics (ATRA) Change in Account Payables (2013 - 2026) Analysis & Trends
Atara Biotherapeutics has reported Change in Account Payables for 14 years, with the latest figure at $510000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 117.1% year-over-year to $510000.0; the trailing twelve-month figure through Mar 2026 stood at -$747000.0 (up 49.18% YoY), and the FY2025 full-year result was -$4.2 million, down 717.18% from the prior year.
- Change in Account Payables for Q1 2026 stood at $510000.0, up from -$191000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $2.5 million in Q3 2023, with the low at -$4.6 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$904941.2 across 5 years, with a median of -$894000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 1346.78% — and 2024, when it jumped 368.34%.
- Atara Biotherapeutics' Change in Account Payables stood at -$4.5 million in 2022, then soared by 36.85% to -$2.8 million in 2023, then surged by 179.12% to $2.2 million in 2024, then plunged by 108.59% to -$191000.0 in 2025, then jumped by 367.02% to $510000.0 in 2026.
- The last three Change in Account Payables figures came in at $510000.0 (Q1 2026), -$191000.0 (Q4 2025), and -$983000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | 510,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 510,000.00 |
| Mar 31, 2026 | 510,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Sep 30, 2025 | -983,000.00 |
| Sep 30, 2025 | -983,000.00 |
| Jun 30, 2025 | -83,000.00 |
| Jun 30, 2025 | -83,000.00 |
| Mar 31, 2025 | -2.98 Mn |
| Mar 31, 2025 | -2.98 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -3.11 Mn |
| Sep 30, 2024 | -3.11 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | -826,000.00 |
| Mar 31, 2024 | -826,000.00 |
| Dec 31, 2023 | -2.81 Mn |
| Dec 31, 2023 | -2.81 Mn |